GBT
Global Blood Therapeutics, Inc.
Delisted
GBT was delisted on the 4th of October, 2022.
223 hedge funds and large institutions have $3.13B invested in Global Blood Therapeutics, Inc. in 2019 Q2 according to their latest regulatory filings, with 51 funds opening new positions, 93 increasing their positions, 47 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
1% less call options, than puts
Call options by funds: $72.6M | Put options by funds: $73.3M
20% less funds holding in top 10
Funds holding in top 10: 10 → 8 (-2)
Holders
223
Holding in Top 10
8
Calls
$72.6M
Puts
$73.3M
Top Buyers
| 1 | +$37.1M | |
| 2 | +$30.1M | |
| 3 | +$25.6M | |
| 4 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
+$23M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$20.6M |
Top Sellers
| 1 | -$95.3M | |
| 2 | -$62.5M | |
| 3 | -$25.9M | |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$19.7M |
| 5 |
State Street
Boston,
Massachusetts
|
-$10.9M |